In this study, elevated expression levels of MED12L in AML patients were found to be markedly correlated with an adverse prognosis, which may be related to abnormal activation or inhibition of the WNT signaling pathway by MED12L. This evidence concerns the gene MED12L and acute myeloid leukemia.